Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

NSD3 Polyclonal antibody

NSD3 Polyclonal Antibody for WB, IHC, IF/ICC, FC (Intra), IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, FC (Intra), IP, chIP, ELISA

WHSC1L1, DC28, EC:2.1.1.370, Histone-lysine N-methyltransferase NSD3, Nuclear SET domain-containing protein 3

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for NSD3 in ?

Tested Applications

Positive WB detected inHeLa cells, HEK-293 cells, rat heart tissue, mouse heart tissue
Positive IP detected inHeLa cells
Positive IHC detected inhuman lung squamous cell carcinoma tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inMCF-7 cells
Positive FC (Intra) detected inNIH/3T3 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:400-1:1600
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 ul suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

11345-1-AP targets NSD3 in WB, IHC, IF/ICC, FC (Intra), IP, chIP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag1894

Product name: Recombinant human WHSC1L1 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-300 aa of BC012059

Sequence: MDFSFSFMQGIMGNTIQQPPQLIDSANIRQEDAFDNNSDIAEDGGQTPYEATLQQGFQYPATTEDLPPLTNGYPSSISVYETQTKYQSYNQYPNGSANGFGAVRNFSPTDYYHSEIPNTRPHEILEKPSPPQPPPPPSVPQTVIPKKTGSPEIKLKITKTIQNGRELFESSLCGDLLNEVQASEHTKSKHESRKEKRKKSNKHDSSRSEERKSHKIPKLEPEEQNRPNERVDTVSEKPREEPVLKEEAPVQPILSSVPTTEVSTGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKI

Predict reactive species
Full Name Wolf-Hirschhorn syndrome candidate 1-like 1
Calculated Molecular Weight 1437 aa, 162 kDa
Observed Molecular Weight 160-170 kDa, 68-72 kDa
GenBank Accession NumberBC012059
Gene Symbol WHSC1L1
Gene ID (NCBI) 54904
RRIDAB_2216189
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9BZ95
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

WHSC1L1, also named as NSD3 and DC28, belongs to the histone-lysine methyltransferase family and SET2 subfamily. It is histone methyltransferase. WHSC1L1 is a potently transforming oncogenes based on the number of altered phenotypes expressed by the cells. It contains a PWWP-domain that is a methyl-lysine recognition motif involved in histone code modification and epigenetic regulation of gene expression. Knockdown of WHSC1L1 in 8p11-12-amplified breast cancer cells resulted in profound loss of growth and survival of these cells. (PMID: 20940404). This antibody recognize the long isoform (160-170 kDa) and short isoform (68-72 kDa).

Protocols

Product Specific Protocols
FC protocol for NSD3 antibody 11345-1-APDownload protocol
IF protocol for NSD3 antibody 11345-1-APDownload protocol
IHC protocol for NSD3 antibody 11345-1-APDownload protocol
IP protocol for NSD3 antibody 11345-1-APDownload protocol
WB protocol for NSD3 antibody 11345-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The NSD3 Polyclonal antibody (Cat# 11345-1-AP) has 21 citations across 19 journals, including Cancer Research, Molecular Cell, Science Advances, Cell Death & Disease, Cell Reports, and Scientific Reports. Research fields span oncology (lung, breast, prostate, pancreatic, and head-and-neck cancers), epigenetics (histone methylation, H3K36), signaling pathways (NOTCH, STAT3, EGFR), drug discovery (NSD3 inhibitors, PARP resistance), and cell cycle regulation. Applications cited include WB, IHC, IF, IP, and ChIP.

SpeciesApplicationTitle
humanIHC

J Thorac Oncol

Translational Analysis of NSD3 Gene Amplification in Lung Squamous Cell Carcinoma: Clinical and Prognostic Insights From Histopathologic Analysis of Patient Samples.

Authors - Shugo Takahashi
humanWB

Cancer Res

Transforming properties of 8p11-12 amplified genes in human breast cancer.

Authors - Yang Zeng-Quan ZQ
  • KD Validated
humanIHC

Cancer Res

NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.

Authors - Ga-Young Jeong
humanWB,IP

Mol Cell

Isoform-specific function of NSD3 in DNA replication stress confers resistance to PARP inhibitors in prostate cancer.

Authors - Shouhai Zhu
  • KD Validated
humanWB

Adv Sci (Weinh)

Histones Methyltransferase NSD3 Inhibits Lung Adenocarcinoma Glycolysis Through Interacting with PPP1CB to Decrease STAT3 Signaling Pathway

Authors - Yanling Zhou
humanWB

Sci Adv

Arginine methylation of BRD4 by PRMT2/4 governs transcription and DNA repair

Authors - Liu Liu
Loading...
||
New chat

Able®

正在加载,请稍候...